Nonserious Infections in Patients With Rheumatoid Arthritis: Results From the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
Author:
Affiliation:
1. Kings College London London UK
2. Manchester Academic Health Sciences Centre University of Manchester NIHR Manchester Biomedical Research Centre, and Manchester University NHS Foundation Trust Manchester UK
Funder
Medical Research Council
Publisher
Wiley
Subject
Immunology,Rheumatology,Immunology and Allergy
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.41754
Reference34 articles.
1. Frequency of infection in patients with rheumatoid arthritis compared with controls: A population-based study
2. Length of Life and Cause of Death in Rheumatoid Arthritis
3. Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis
4. Predictors of infection in rheumatoid arthritis
5. The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effect of different DMARD use on the frequency of urinary infection in patients with rheumatoid arthritis;Anatolian Current Medical Journal;2024-01-15
2. Glucocorticoïdes et polyarthrite rhumatoïde : trouver l’équilibre bénéfice–préjudice en exploitant la fenêtre d’opportunité thérapeutique;Revue du Rhumatisme;2023-10
3. Incidence of infections in patients with psoriatic arthritis and axial spondyloarthritis treated with biological or targeted disease-modifying agents: a systematic review and meta-analysis of randomised controlled trials, open-label studies and observational studies;RMD Open;2023-09
4. Prediction of flare following glucocorticoids withdrawal in rheumatoid arthritis patients with continuation of csDMARDs: a real-life study;Internal and Emergency Medicine;2023-07-07
5. Infection incidence, timing and dose dependency in rheumatoid arthritis patients treated with rituximab: a retrospective cohort study;Rheumatology;2023-07-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3